Prostate Cancer
Descriptive analysis of prostate cancer pathology data from diagnosis and surgery in men from the 45 and Up Study.
December 18, 2023
Prostate-Specific Membrane Antigen-Targeted Therapies for Prostate Cancer: Towards Improving Therapeutic Outcomes.
December 18, 2023
Feasibility of a novel wearable thermal device for management of bothersome hot flashes in patients with prostate cancer.
December 15, 2023
Medium-term follow up of active surveillance for early prostate cancer at a non-academic institution.
December 15, 2023
Intensity modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: five-year outcomes.
December 15, 2023
Prediction of T staging in PI-RADS 4-5 prostate cancer by combination of multiparametric MRI and 68Ga-PSMA-11 PET/CT.
December 15, 2023
The PRIMARY Score: Diagnostic Performance and Added Value Compared With MRI in Detecting Clinically Significant Prostate Cancer.
December 15, 2023
Engaging communities to inform the development of a diverse cohort of cancer survivors: formative research for the eat move sleep study (EMOVES).
December 14, 2023
Network connectivity between psychological resilience and depression in prostate cancer patients.
December 14, 2023
Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System.
December 14, 2023
Inequities in Definitive Treatment for Localized Prostate Cancer Among Those With Clinically Significant Mental Health Disorders.
December 14, 2023
Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in AR -altered lethal prostate cancer.
December 13, 2023
The effects of glycemic index on prostate cancer progression in a xenograft mouse model.
December 13, 2023
Pilot Trial of Streamlined Genetic Education and Traceback Genetic Testing in Prostate Cancer Survivors.
December 13, 2023
The Brazilian national prospective active surveillance (AS) cohort of patients with low-risk prostate cancer in the public health system: vigiaSUS study protocol.
December 13, 2023